[CLBS] Caladrius Biosciences, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Hospital/Nursing Management

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.93 Change: -0.21 (-6.69%)
Ext. hours: Change: 0 (0%)

chart CLBS

Refresh chart

Strongest Trends Summary For CLBS

CLBS is in the medium-term up 31% in 6 months. In the long-term down -61% below S&P in 2 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities7.49 M Cash From Investing Activities6.7 M Cash From Operating Activities-14.24 M Gross Profit-200 K
Net Profit-19.19 M Operating Profit-18.09 M Total Assets118.81 M Total Current Assets29.02 M
Total Current Liabilities17.46 M Total Debt16.72 M Total Liabilities68.41 M Total Revenue3.17 M
Technical Data
High 52 week5.32 Low 52 week2.02 Last close2.73 Last change-2.15%
RSI73.39 Average true range0.22 Beta0.5 Volume68.63 K
Simple moving average 20 days16.72% Simple moving average 50 days13.51% Simple moving average 200 days-6.81%
Performance Data
Performance Week2.25% Performance Month22.97% Performance Quart14.71% Performance Half-9.3%
Performance Year-39.6% Performance Year-to-date-23.31% Volatility daily4.68% Volatility weekly10.47%
Volatility monthly21.46% Volatility yearly74.34% Relative Volume332.17% Average Volume22.88 K
New High New Low-4.56%

News

2020-05-28 13:20:41 | Caladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

2020-05-26 08:00:10 | Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

2020-05-14 15:42:22 | Caladrius Biosciences Reports Positive Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions

2020-05-12 11:15:03 | Simple Market Timing Strategies That Work - May 12, 2020

2020-05-11 21:50:32 | Edited Transcript of CLBS earnings conference call or presentation 7-May-20 8:30pm GMT

2020-05-07 16:05:10 | Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results

2020-05-06 08:30:10 | Caladrius Biosciences Announces Presentation of Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions

2020-04-30 08:30:10 | Caladrius Biosciences to Host First Quarter 2020 Financial Results Conference Call on Thursday, May 7, 2020

2020-04-27 15:16:58 | Caladrius Biosciences Closes $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

2020-04-23 14:00:10 | Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

2020-04-23 08:55:58 | Caladrius Biosciences Plans to Assess its CLBS119 Cell Therapy for Repair of COVID-19 Induced Lung Damage

2020-04-22 08:00:10 | Caladrius Biosciences to Receive $10.9 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program

2020-04-20 07:14:32 | We're Keeping An Eye On Caladrius Biosciences's NASDAQ:CLBS Cash Burn Rate

2020-03-25 00:47:29 | Edited Transcript of CLBS earnings conference call or presentation 5-Mar-20 9:30pm GMT

2020-03-17 07:00:00 | Memgen Appoints Gregory Brown as Chief Executive Officer

2020-03-06 09:22:02 | The Truth About Market Timing - March 06, 2020

2020-03-05 16:05:10 | Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

2020-03-05 14:30:00 | Caladrius Biosciences, Inc. to Host Earnings Call

2020-02-27 08:30:10 | Caladrius Biosciences to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Thursday, March 5, 2020 at 4:30 p.m. Eastern Time

2020-02-03 08:30:10 | Caladrius Biosciences to Participate at Upcoming February Conferences

2020-01-27 09:17:02 | The Market Timing Secrets No One Talks About - January 27, 2020

2020-01-21 07:35:47 | Does Caladrius Biosciences, Inc. NASDAQ:CLBS Have A Particularly Volatile Share Price?

2020-01-07 16:05:10 | Caladrius Biosciences to Participate at Upcoming January Conferences

2020-01-07 10:00:17 | Simple Market Timing Strategies That Work - January 07, 2020

2019-12-02 16:05:10 | Caladrius Biosciences to Participate at Upcoming December Conferences

2019-11-25 09:37:16 | Timing the Market, Is it Possible? - November 25, 2019

2019-11-16 20:13:50 | Edited Transcript of CLBS earnings conference call or presentation 6-Nov-19 9:30pm GMT

2019-11-16 15:59:08 | Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019

2019-11-06 16:05:00 | Caladrius Biosciences Reports 2019 Third Quarter and Nine Month Financial Results and Provides Corporate Update

2019-11-04 08:44:01 | When Does Market Timing Actually Work? - November 04, 2019

2019-10-31 08:30:05 | Caladrius Biosciences to Participate at Upcoming November Conferences

2019-10-30 08:30:05 | Caladrius Biosciences to Host 2019 Third Quarter Financial Results and Business Update Conference Call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time

2019-10-23 11:30:33 | Is Caladrius Biosciences NASDAQ:CLBS In A Good Position To Deliver On Growth Plans?

2019-10-14 08:36:12 | The Market Timing Secrets No One Talks About - October 14, 2019

2019-10-01 08:30:00 | Caladrius Biosciences to Participate at the Upcoming October Conferences

2019-09-24 09:04:01 | The Keys to Successfully Timing the Markets - September 24, 2019

2019-09-06 10:15:45 | CORRECTING and REPLACING -- Caladrius Biosciences to Participate at the Upcoming September Conferences

2019-09-05 16:05:00 | Caladrius Biosciences to Participate at the Upcoming September Conferences

2019-09-04 08:58:12 | The Keys to Successfully Timing the Markets - September 04, 2019

2019-08-15 09:57:01 | The Keys to Successful Timing the Markets - August 15, 2019

2019-08-09 06:38:08 | Edited Transcript of CLBS earnings conference call or presentation 8-Aug-19 8:30pm GMT

2019-08-08 16:05:00 | Caladrius Biosciences Reports 2019 Second Quarter and First Six Months Financial Results and Provides Corporate Update

2019-08-07 08:30:00 | Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina

2019-08-05 10:55:02 | Top Ranked Momentum Stocks to Buy for August 5th

2019-08-01 08:30:00 | Caladrius Biosciences to Host 2019 Second Quarter Financial Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. Eastern Time

2019-07-25 15:04:06 | If You Had Bought Caladrius Biosciences NASDAQ:CLBS Stock Five Years Ago, You'd Be Sitting On A 95% Loss, Today

2019-07-25 11:27:03 | Top Ranked Momentum Stocks to Buy for July 25th

2019-07-15 08:30:00 | Caladrius Biosciences Receives Advanced Therapy Medicinal Product Classification for CLBS12, its CD34+ Cell Therapy for Critical Limb Ischemia

2019-06-04 08:30:00 | Caladrius Biosciences Completes Enrollment in Phase 2 ESCaPE-CMD Trial for Coronary Microvascular Dysfunction

2019-05-10 18:11:18 | Edited Transcript of CLBS earnings conference call or presentation 9-May-19 8:30pm GMT